Loading...
•
Dec 31, 2025
IDEXX Q4 2025 Earnings Report
IDEXX delivered strong fourth-quarter growth driven by diagnostics and margin expansion.
Key Takeaways
IDEXX reported strong Q4 2025 results with double-digit revenue growth, solid EPS expansion, and operating margin improvement led by Companion Animal Group diagnostics and record instrument placements.
Q4 revenue grew double digits driven by Companion Animal Group diagnostics.
EPS increased significantly supported by operating margin expansion.
Record quarterly instrument placements strengthened the installed base.
Strong execution offset inflationary pressures.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company provided initial 2026 guidance expecting continued revenue and EPS growth driven by diagnostics and price realization.
Positive Outlook
- Expected continued CAG diagnostics growth.
- Ongoing expansion of premium instrument installed base.
- Net price improvement expected to support revenue.
- Operating margin improvement targeted.
- Strong innovation pipeline entering 2026.
Challenges Ahead
- Macroeconomic uncertainty could impact demand.
- Foreign currency volatility may affect results.
- Inflationary pressures remain a risk.
- Dependence on veterinary visit trends.
- Potential regulatory and trade policy impacts.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...